XTX Topco Ltd Has $246,000 Position in Chemed Corporation (NYSE:CHE)

XTX Topco Ltd lowered its position in Chemed Corporation (NYSE:CHE) by 92.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 400 shares of the company’s stock after selling 4,881 shares during the period. XTX Topco Ltd’s holdings in Chemed were worth $246,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Mackenzie Financial Corp increased its holdings in Chemed by 1.4% in the first quarter. Mackenzie Financial Corp now owns 4,694 shares of the company’s stock worth $2,888,000 after buying an additional 65 shares during the last quarter. LPL Financial LLC boosted its position in Chemed by 12.7% during the first quarter. LPL Financial LLC now owns 10,527 shares of the company’s stock worth $6,477,000 after purchasing an additional 1,185 shares during the period. Inspire Advisors LLC acquired a new position in Chemed during the first quarter valued at approximately $221,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Chemed by 4.2% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,550 shares of the company’s stock valued at $2,184,000 after purchasing an additional 144 shares during the last quarter. Finally, First Heartland Consultants Inc. grew its holdings in Chemed by 6.7% during the first quarter. First Heartland Consultants Inc. now owns 673 shares of the company’s stock valued at $414,000 after purchasing an additional 42 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CHE. Bank of America lowered their price target on Chemed from $708.00 to $650.00 and set a “buy” rating on the stock in a report on Monday, June 30th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a report on Saturday, July 5th. Royal Bank Of Canada lowered their price target on Chemed from $640.00 to $589.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Jefferies Financial Group began coverage on Chemed in a report on Friday, July 25th. They set a “hold” rating and a $500.00 price target on the stock. Finally, Oppenheimer lowered their price target on Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $579.75.

Insider Buying and Selling at Chemed

In related news, Director George J. Walsh III acquired 200 shares of the business’s stock in a transaction on Monday, August 4th. The stock was bought at an average cost of $417.10 per share, with a total value of $83,420.00. Following the completion of the acquisition, the director owned 3,523 shares in the company, valued at $1,469,443.30. The trade was a 6.02% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Nicholas Michael Westfall sold 10,012 shares of Chemed stock in a transaction on Monday, August 4th. The shares were sold at an average price of $421.91, for a total value of $4,224,162.92. The disclosure for this sale can be found here. Company insiders own 3.29% of the company’s stock.

Chemed Trading Down 0.7%

CHE opened at $432.47 on Tuesday. The stock has a market capitalization of $6.30 billion, a price-to-earnings ratio of 22.23, a P/E/G ratio of 2.40 and a beta of 0.46. Chemed Corporation has a 1-year low of $408.42 and a 1-year high of $623.60. The business has a 50 day moving average of $491.79 and a 200-day moving average of $547.62.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing the consensus estimate of $6.02 by ($1.75). The firm had revenue of $618.80 million during the quarter, compared to the consensus estimate of $650.60 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%. The firm’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period last year, the business earned $5.47 earnings per share. Equities analysts predict that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Monday, August 11th will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, August 11th. This is a boost from Chemed’s previous quarterly dividend of $0.50. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is 10.28%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.